Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
ModernVivo
AddedFeb 18, 2024
UpdatedJun 18, 2026
ModernVivo

ModernVivo

ModernVivo revolutionizes preclinical study design with tools for efficient protocol creation, enhancing drug development success.

HQ
Seattle, WA, US
Founded
2022
Overview
Compare
Fundraising
Employees

ModernVivo's core mission is to revolutionize preclinical study design, aiming to enhance the success rate of drug development. They offer tools for efficient protocol creation, addressing the inefficiencies and high failure rates in preclinical animal studies. Their market focus is on in-vivo scientists and pharmaceutical companies seeking to streamline the experimental design process and improve clinical trial outcomes.

ModernVivo has achieved significant impact by reducing the time and effort required for designing preclinical studies, thus accelerating the drug development pipeline. Their innovative approach has garnered attention within the pharmaceutical industry, contributing to more reliable and predictive preclinical results.

ModernVivo - Similar Companies

Vivodyne logo

Vivodyne

vivodyne.com

Vevo Therapeutics logo

Vevo Therapeutics

vevo.ai

Genemod logo

Genemod

genemod.net

Viking Scientific logo

Viking Scientific

NextVivo logo

NextVivo

nextvivo.bio

Maven Bio logo

Maven Bio

mavenbio.io

Verisim Life logo

Verisim Life

verisimlife.com

PhaseV logo

PhaseV

phasevtrials.com

Parallel Bio logo

Parallel Bio

parallel.bio

Jeeva logo

Jeeva

jeevatrials.com

Curie.Bio logo

Curie.Bio

curie.bio

Vial logo

Vial

vialtrials.com

Livivos logo

Livivos

livivos.com

Mdverse logo

Mdverse

mdverse.io

Radicle Science logo

Radicle Science

radiclescience.com

ModernVivo - Quick Facts

Who are ModernVivo's competitors?

Companies similar to ModernVivo include Vivodyne, Vevo Therapeutics, Genemod and Viking Scientific.

When was ModernVivo founded?

ModernVivo was founded in 2022.

Where is ModernVivo's headquarters located?

ModernVivo's headquarters is located in Seattle, WA, US.

When was ModernVivo's last funding round?

ModernVivo's most recent funding round was for $100k (USD) in September 2023.

How much has ModernVivo raised to-date?

As of Sep 27, 2023, ModernVivo has raised a total of $146.5k (USD).

How many employees does ModernVivo have?

ModernVivo has 5 employees as of Feb 4, 2024.

ModernVivo - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software